<SEC-DOCUMENT>0001354457-26-000086.txt : 20260126
<SEC-HEADER>0001354457-26-000086.hdr.sgml : 20260126
<ACCEPTANCE-DATETIME>20260126141042
ACCESSION NUMBER:		0001354457-26-000086
CONFORMED SUBMISSION TYPE:	25-NSE/A
CONFIRMING COPY:	
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20260126
DATE AS OF CHANGE:		20260126

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Astria Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001454789
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		25-NSE/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37467

	BUSINESS ADDRESS:	
		STREET 1:		22 BOSTON WHARF ROAD
		STREET 2:		10TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210
		BUSINESS PHONE:		617-349-1971

	MAIL ADDRESS:	
		STREET 1:		22 BOSTON WHARF ROAD
		STREET 2:		10TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CATABASIS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20090127

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nasdaq Stock Market LLC
		CENTRAL INDEX KEY:			0001354457
		ORGANIZATION NAME:           	
		EIN:				521165937
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		25-NSE/A

	BUSINESS ADDRESS:	
		STREET 1:		One Liberty Plaza
		CITY:			New York
		STATE:			NY
		ZIP:			10006
		BUSINESS PHONE:		301-978-4144

	MAIL ADDRESS:	
		STREET 1:		Office of General Counsel
		STREET 2:		805 King Farm Blvd.
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	The Nasdaq Stock Market LLC
		DATE OF NAME CHANGE:	20060224
</SEC-HEADER>
<DOCUMENT>
<TYPE>25-NSE/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.25
<SEQUENCE>2
<FILENAME>atxs-form25.txt
</DOCUMENT>
</SUBMISSION>